- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3010EUR$3,250USD£2,525GBP
- Report
- January 2022
- 200 Pages
Global
From €6947EUR$7,500USD£5,827GBP
- Report
- April 2020
- 80 Pages
Global
From €3659EUR$3,950USD£3,069GBP
- Report
- April 2023
- 110 Pages
Global
From €4400EUR$4,750USD£3,690GBP
- Report
- April 2023
- 111 Pages
Global
From €4400EUR$4,750USD£3,690GBP
- Report
- April 2023
- 110 Pages
Global
From €4400EUR$4,750USD£3,690GBP
- Report
- October 2022
- 113 Pages
Global
From €4400EUR$4,750USD£3,690GBP
- Report
- August 2022
- 120 Pages
Global
From €4400EUR$4,750USD£3,690GBP
- Report
- September 2024
- 82 Pages
Japan
From €3242EUR$3,500USD£2,719GBP
- Report
- August 2024
- 85 Pages
India
From €3242EUR$3,500USD£2,719GBP
- Report
- August 2024
- 82 Pages
Japan
From €3242EUR$3,500USD£2,719GBP
- Report
- November 2023
- 81 Pages
Germany
From €3242EUR$3,500USD£2,719GBP
- Report
- November 2023
- 90 Pages
France
From €3242EUR$3,500USD£2,719GBP
- Report
- October 2023
- 81 Pages
Japan
From €3242EUR$3,500USD£2,719GBP
- Report
- July 2023
- 78 Pages
United States
From €3242EUR$3,500USD£2,719GBP
- Report
- March 2023
- 117 Pages
Global
From €4539EUR$4,900USD£3,807GBP
- Report
- December 2022
- 111 Pages
Global
From €4539EUR$4,900USD£3,807GBP
- Report
- May 2023
- 200 Pages
Global
From €6947EUR$7,500USD£5,827GBP
- Report
- May 2023
- 220 Pages
Global
From €2316EUR$2,500USD£1,942GBP
- Report
- May 2023
- 450 Pages
Global
From €4631EUR$5,000USD£3,884GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more